{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,14]],"date-time":"2026-04-14T02:06:09Z","timestamp":1776132369877,"version":"3.50.1"},"reference-count":34,"publisher":"Springer Science and Business Media LLC","issue":"1","content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Malar J"],"published-print":{"date-parts":[[2015,12]]},"DOI":"10.1186\/s12936-015-0810-4","type":"journal-article","created":{"date-parts":[[2015,7,30]],"date-time":"2015-07-30T12:32:19Z","timestamp":1438259539000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":20,"title":["Measuring windows of selection for anti-malarial drug treatments"],"prefix":"10.1186","volume":"14","author":[{"given":"Katherine","family":"Kay","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ian M","family":"Hastings","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2015,7,31]]},"reference":[{"key":"810_CR1","unstructured":"WHO Guidelines for the treatment of malaria (second edition) (2010). World Health Organization, Geneva, http:\/\/whqlibdoc.who.int\/publications\/2010\/9789241547925_eng.pdf"},{"key":"810_CR2","doi-asserted-by":"crossref","first-page":"1014","DOI":"10.1086\/427997","volume":"191","author":"C Sisowath","year":"2005","unstructured":"Sisowath C, Str\u00f6mberg J, M\u00e5rtensson A, Msellem M, Obondo C, Bj\u00f6rkman A et al (2005) In vivo selection of Plasmodium falciparum pfmdr1 86N coding alleles by artemether\u2013lumefantrine (Coartem). J Infect Dis 191:1014\u20131017","journal-title":"J Infect Dis"},{"key":"810_CR3","doi-asserted-by":"crossref","first-page":"736","DOI":"10.1111\/j.1365-3156.2007.01843.x","volume":"12","author":"C Sisowath","year":"2007","unstructured":"Sisowath C, Ferreira PE, Bustamante LY, Dahlstr\u00f6m S, M\u00e5rtensson A, Bj\u00f6rkman A et al (2007) The role of pfmdr1 in Plasmodium falciparum tolerance to artemether\u2013lumefantrine in Africa. Trop Med Int Health 12:736\u2013742","journal-title":"Trop Med Int Health"},{"key":"810_CR4","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1098\/rstb.2001.1036","volume":"357","author":"IM Hastings","year":"2002","unstructured":"Hastings IM, Watkins WM, White NJ (2002) The evolution of drug-resistant malaria: the role of drug elimination half-life. Phil Trans R Soc Lond B 357:505\u2013519","journal-title":"Phil Trans R Soc Lond B"},{"key":"810_CR5","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1016\/j.pt.2005.12.011","volume":"22","author":"IM Hastings","year":"2006","unstructured":"Hastings IM, Watkins WM (2006) Tolerance is the key to understanding antimalarial drug resistance. Trends Parasitol 22:71\u201377","journal-title":"Trends Parasitol"},{"key":"810_CR6","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1016\/0035-9203(93)90431-O","volume":"87","author":"WM Watkins","year":"1993","unstructured":"Watkins WM, Mosobo M (1993) Treatment of Plasmodium falciparum malaria with pyrimethamine-sulfadoxine: selective pressure for resistance is a function of long elimination half-life. Trans R Soc Trop Med Hyg 87:75\u201378","journal-title":"Trans R Soc Trop Med Hyg"},{"key":"810_CR7","doi-asserted-by":"crossref","first-page":"452","DOI":"10.1016\/j.pt.2003.08.003","volume":"19","author":"L Seidlein von","year":"2003","unstructured":"von Seidlein L, Greenwood BM (2003) Mass administrations of antimalarial drugs. Trends Parasitol 19:452\u2013460","journal-title":"Trends Parasitol"},{"key":"810_CR8","unstructured":"WHO (2015) Malaria: draft global technical strategy: post 2015. World Health Organization, Geneva. http:\/\/apps.who.int\/gb\/ebwha\/pdf_files\/WHA68\/A68_28-en.pdf?ua=1"},{"key":"810_CR9","first-page":"1","volume-title":"Global plan for artemisinin resistance containment","author":"WHO","year":"2011","unstructured":"WHO (2011) Global plan for artemisinin resistance containment. World Health Organization, Geneva, pp 1\u201388"},{"key":"810_CR10","first-page":"1","volume-title":"Emergency response to artemisinin resistance in the greater Mekong subregion. Regional Framework for action 2013\u20132015","author":"WHO","year":"2013","unstructured":"WHO (2013) Emergency response to artemisinin resistance in the greater Mekong subregion. Regional Framework for action 2013\u20132015. World Health Organization, Geneva, pp 1\u201332"},{"key":"810_CR11","first-page":"1","volume-title":"Consideration of mass drug administration for the containment of artemisinin-resistant malaria in the Greater Mekong subregion: report of a consensus meeting, 27\u201328 September 2010","author":"WHO","year":"2011","unstructured":"WHO (2011) Consideration of mass drug administration for the containment of artemisinin-resistant malaria in the Greater Mekong subregion: report of a consensus meeting, 27\u201328 September 2010. World Health Organization, Geneva, pp 1\u201340"},{"key":"810_CR12","doi-asserted-by":"crossref","first-page":"1471","DOI":"10.1016\/S0140-6736(00)04643-2","volume":"357","author":"D Schellenberg","year":"2001","unstructured":"Schellenberg D, Menendez C, Kahigwa E, Aponte J, Vidal J, Tanner M et al (2001) Intermittent treatment for malaria and anaemia control at time of routine vaccinations in Tanzanian infants: a randomised, placebo-controlled trial. Lancet 357:1471\u20131477","journal-title":"Lancet"},{"key":"810_CR13","doi-asserted-by":"crossref","first-page":"659","DOI":"10.1016\/S0140-6736(06)68264-0","volume":"367","author":"B Ciss\u00e9","year":"2006","unstructured":"Ciss\u00e9 B, Sokhna C, Boulanger D, Milet J, B\u00e2 EH, Richardson K et al (2006) Seasonal intermittent preventive treatment with artesunate and sulfadoxine-pyrimethamine for prevention of malaria in Senegalese children: a randomised, placebo-controlled, double-blind trial. Lancet 367:659\u2013667","journal-title":"Lancet"},{"key":"810_CR14","first-page":"1963","volume":"192","author":"F Marks","year":"2005","unstructured":"Marks F, von Kalckreuth V, Kobbe R, Adjei S, Adjei O, Horstmann RD et al (2005) Parasitological rebound effect and emergence of pyrimethamine resistance in Plasmodium falciparum after single-dose sulfadoxine-pyrimethamine. J Infect Dis 192:1963\u20131965","journal-title":"J Infect Dis"},{"key":"810_CR15","doi-asserted-by":"crossref","first-page":"1303","DOI":"10.1086\/432554","volume":"192","author":"I Hastings","year":"2005","unstructured":"Hastings I, Ward S (2005) Coartem (Artemether\u2013Lumefantrine) in Africa: the beginning of the end? J Infect Dis 192:1303\u20131304","journal-title":"J Infect Dis"},{"key":"810_CR16","doi-asserted-by":"crossref","first-page":"1088","DOI":"10.1086\/655779","volume":"202","author":"EM Hodel","year":"2010","unstructured":"Hodel EM, Genton B, Zanolari B, Mercier T, Duong S, Beck HP et al (2010) Residual antimalarial concentrations before treatment in patients with malaria from Cambodia: indication of drug pressure. J Infect Dis 202:1088\u20131094","journal-title":"J Infect Dis"},{"key":"810_CR17","doi-asserted-by":"crossref","first-page":"e8184","DOI":"10.1371\/journal.pone.0008184","volume":"4","author":"EM Hodel","year":"2009","unstructured":"Hodel EM, Kabanywanyi AM, Malila A, Zanolari B, Mercier T, Beck HP et al (2009) Residual antimalarials in malaria patients from Tanzania\u2014implications on drug efficacy assessment and spread of parasite resistance. PLoS One 4:e8184","journal-title":"PLoS One"},{"key":"810_CR18","doi-asserted-by":"crossref","first-page":"310","DOI":"10.1016\/S0035-9203(02)90108-2","volume":"96","author":"A Talisuna","year":"2002","unstructured":"Talisuna A, Langi P, Bakyaita N, Egwang T, Mutabingwa T, Watkins W et al (2002) Intensity of malaria transmission, antimalarial drug use and resistance in Uganda: what is the relationship between these three factors? Trans R Soc Trop Med Hyg 96:310\u2013317","journal-title":"Trans R Soc Trop Med Hyg"},{"key":"810_CR19","doi-asserted-by":"crossref","first-page":"1589","DOI":"10.1128\/AAC.00903-07","volume":"52","author":"K Stepniewska","year":"2008","unstructured":"Stepniewska K, White NJ (2008) Pharmacokinetic determinants of the window of selection for antimalarial drug resistance. Antimicrob Agents 52:1589\u20131596","journal-title":"Antimicrob Agents"},{"key":"810_CR20","doi-asserted-by":"crossref","first-page":"3380","DOI":"10.1128\/AAC.01712-10","volume":"55","author":"K Winter","year":"2011","unstructured":"Winter K, Hastings IM (2011) Development, evaluation, and application of an in silico model for antimalarial drug treatment and failure. Antimicrob Agents Chemother 55:3380\u20133392","journal-title":"Antimicrob Agents Chemother"},{"key":"810_CR21","doi-asserted-by":"crossref","first-page":"e1003151","DOI":"10.1371\/journal.pcbi.1003151","volume":"9","author":"K Kay","year":"2013","unstructured":"Kay K, Hastings IM (2013) Improving pharmacokinetic\u2013pharmacodynamic modeling to investigate anti-infective chemotherapy with application to the current generation of antimalarial drugs. PLoS Comput Biol 9:e1003151","journal-title":"PLoS Comput Biol"},{"key":"810_CR22","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1186\/1475-2875-13-138","volume":"13","author":"EM Hodel","year":"2014","unstructured":"Hodel EM, Kay K, Hayes D, Terlouw D, Hastings I (2014) Optimizing the programmatic deployment of the anti-malarials artemether\u2013lumefantrine and dihydroartemisinin\u2013piperaquine using pharmacological modelling. Malar J 13:138","journal-title":"Malar J"},{"key":"810_CR23","first-page":"1","volume-title":"Assessment and monitoring of antimalarial drug efficacy for the treatment of uncomplicated falciparum malaria","author":"WHO","year":"2003","unstructured":"WHO (2003) Assessment and monitoring of antimalarial drug efficacy for the treatment of uncomplicated falciparum malaria. World Health Organization, Geneva, pp 1\u201367"},{"key":"810_CR24","doi-asserted-by":"crossref","first-page":"3269","DOI":"10.1002\/sim.2189","volume":"24","author":"W Sama","year":"2005","unstructured":"Sama W, Owusu-Agyei S, Felger I, Vounatsou P, Smith T (2005) An immigration\u2014death model to estimate the duration of malaria infection when detectability of the parasite is imperfect. Stat Med 24:3269\u20133288","journal-title":"Stat Med"},{"key":"810_CR25","doi-asserted-by":"crossref","first-page":"655","DOI":"10.4269\/ajtmh.2008.79.655","volume":"79","author":"I Sagara","year":"2008","unstructured":"Sagara I, Diallo A, Kone M, Coulibaly M, Diawara SI, Guindo O et al (2008) A randomized trial of artesunate\u2013mefloquine versus artemether\u2013lumefantrine for treatment of uncomplicated Plasmodium falciparum malaria in Mali. Am J Trop Med Hyg 79:655\u2013661","journal-title":"Am J Trop Med Hyg"},{"key":"810_CR26","doi-asserted-by":"crossref","first-page":"1589","DOI":"10.1128\/AAC.00903-07","volume":"52","author":"K Stepniewska","year":"2008","unstructured":"Stepniewska K, White NJ (2008) Pharmacokinetic determinants of the window of selection for antimalarial drug resistance. Antimicrob Agents Chemother 52:1589\u20131596","journal-title":"Antimicrob Agents Chemother"},{"key":"810_CR27","doi-asserted-by":"crossref","unstructured":"Hodel EMS, Guidi M, Zanolari B, Mercier T, Duong S, Kabanywanyi AM et al (2013) Population pharmacokinetics of mefloquine, piperaquine and artemether\u2013lumefantrine in Cambodian and Tanzanian malaria patients. Malar J 12:235. doi: 10.1186\/1475-2875-12-235","DOI":"10.1186\/1475-2875-12-235"},{"key":"810_CR28","unstructured":"WHO (2008) Medicines for malaria venture: methods and techniques for clinical trials on antimalarial drug efficacy: genotyping to identify parasite populations. World Health Organization, Geneva, pp 1\u201354. http:\/\/www.who.int\/malaria\/publications\/atoz\/9789241596305\/en\/"},{"key":"810_CR29","first-page":"1455","volume":"140","author":"T Anderson","year":"2011","unstructured":"Anderson T, Standwell N, Ecker A, Fidock D (2011) How can we identify parasite genes that underlie antimalarial drug resistance? Pharmacogenomics 140:1455\u20131467","journal-title":"Pharmacogenomics"},{"key":"810_CR30","doi-asserted-by":"crossref","first-page":"1455","DOI":"10.1017\/S0031182013000954","volume":"140","author":"JM Mwangi","year":"2013","unstructured":"Mwangi JM, Ranford-Cartwright L (2013) Genetic and genomic approaches for the discovery of parasite genes involved in antimalarial drug resistance. Parasitology 140:1455\u20131467","journal-title":"Parasitology"},{"key":"810_CR31","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1016\/j.pt.2010.09.005","volume":"27","author":"I Hastings","year":"2011","unstructured":"Hastings I (2011) How artemisinin-containing combination therapies slow the spread of antimalarial drug resistance. Trends Parasitol 27:67\u201372","journal-title":"Trends Parasitol"},{"key":"810_CR32","doi-asserted-by":"crossref","first-page":"19914","DOI":"10.1073\/pnas.0707766104","volume":"104","author":"AR Wargo","year":"2007","unstructured":"Wargo AR, Huijben S, de Roode JC, Shepherd J, Read AF (2007) Competitive release and facilitation of drug-resistant parasites after therapeutic chemotherapy in a rodent malaria model. Proc Natl Acad Sci USA 104:19914\u201319919","journal-title":"Proc Natl Acad Sci USA"},{"key":"810_CR33","doi-asserted-by":"crossref","first-page":"9027","DOI":"10.1073\/pnas.0901415106","volume":"106","author":"WE Harrington","year":"2009","unstructured":"Harrington WE, Mutabingwa TK, Muehlenbachs A, Sorensen B, Bolla MC, Fried M et al (2009) Competitive facilitation of drug-resistant Plasmodium falciparum malaria parasites in pregnant women who receive preventive treatment. Proc Natl Acad Sci USA 106:9027\u20139032","journal-title":"Proc Natl Acad Sci USA"},{"key":"810_CR34","first-page":"1","volume-title":"World malaria report","author":"WHO","year":"2011","unstructured":"WHO (2011) World malaria report. World Health Organization, Geneva, pp 1\u2013278"}],"container-title":["Malaria Journal"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12936-015-0810-4","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,8,28]],"date-time":"2019-08-28T22:29:41Z","timestamp":1567031381000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.malariajournal.com\/content\/14\/1\/292"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,7,31]]},"references-count":34,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2015,12]]}},"alternative-id":["810"],"URL":"https:\/\/doi.org\/10.1186\/s12936-015-0810-4","relation":{},"ISSN":["1475-2875"],"issn-type":[{"value":"1475-2875","type":"electronic"}],"subject":[],"published":{"date-parts":[[2015,7,31]]},"article-number":"292"}}